Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

GT, Everson; KD, Sims; M, Rodriguez-Torres; C, Hézode; E, Lawitz; M, Bourlière; V, Loustaud-Ratti; V, Rustgi; H, Schwartz; H, Tatum; P, Marcellin; S, Pol; PJ, Thuluvath; T, Eley; X, Wang; SP, Huang; F, McPhee; M, Wind-Rotolo; E, Chung; C, Pasquinelli; DM, Grasela; DF, Gardiner

doi:10.1053/j.gastro.2013.10.057

Public

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

Shared by NobleBlocks on Oct 30, 2013 • 12:00 AM UTC

Authors:

Everson GT

Sims KD

Rodriguez-Torres M

Abstract

Background & aims The combination of peginterferon and ribavirin with telaprevir or boceprevir is the standard treatment of hepatitis C virus (HCV) genotype 1 infection. However, these drugs are not well tolerated because of their side effects and suboptimal virologic responses. In a phase 2a, open-...

Subject

Genotype

HCV

Therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!